Legal & General Group PLC Novo Cure LTD Transaction History

Legal & General Group PLC

  • $431 Billion
  • Q3 2025

A detailed history of Legal & General Group PLC transactions in Novo Cure LTD stock. As of the latest transaction made, Legal & General Group PLC holds 245,569 shares of NVCR stock, worth $2.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
245,569
Previous 194,653 26.16%
Holding current value
$2.78 Million
Previous $3.46 Million 8.43%
% of portfolio
0.0%
Previous 0.0%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$10.9 - $18.46 $554,984 - $939,909
50,916 Added 26.16%
245,569 $3.17 Million
Q2 2025

Aug 12, 2025
BUY
$15.37 - $19.4 $463,205 - $584,657
30,137 Added 18.32%
194,653 $3.46 Million
Q1 2025

May 15, 2025
BUY
$17.82 - $30.19 $120,427 - $204,024
6,758 Added 4.28%
164,516 $2.93 Million
Q4 2024

Feb 13, 2025
SELL
$14.54 - $33.41 $387,549 - $890,510
-26,654 Reduced 14.45%
157,758 $4.7 Million
Q3 2024

Feb 28, 2025
BUY
$15.61 - $23.34 $225,517 - $337,192
14,447 Added 9.16%
172,205 $2.69 Million
Q3 2024

Nov 14, 2024
BUY
$15.61 - $23.34 $189,833 - $283,837
12,161 Added 7.06%
184,412 $2.88 Million
Q2 2024

May 29, 2025
SELL
$11.83 - $24.05 $106,801 - $217,123
-9,028 Reduced 5.34%
160,044 $2.74 Million
Q2 2024

Aug 14, 2024
BUY
$11.83 - $24.05 $37,607 - $76,454
3,179 Added 1.88%
172,251 $2.95 Million
Q1 2024

May 29, 2025
BUY
$12.42 - $17.29 $56,585 - $78,773
4,556 Added 2.77%
169,072 $2.64 Million
Q1 2024

May 14, 2024
SELL
$12.42 - $17.29 $291,075 - $405,208
-23,436 Reduced 12.17%
169,072 $2.64 Million
Q4 2023

May 29, 2025
BUY
$11.13 - $15.78 $311,550 - $441,713
27,992 Added 17.01%
192,508 $2.87 Million
Q4 2023

Feb 15, 2024
BUY
$11.13 - $15.78 $152,525 - $216,249
13,704 Added 7.66%
192,508 $2.87 Million
Q3 2023

Nov 14, 2023
SELL
$16.15 - $42.35 $5.38 Million - $14.1 Million
-332,824 Reduced 65.05%
178,804 $2.89 Million
Q2 2023

Aug 14, 2023
BUY
$40.29 - $82.51 $2.82 Million - $5.78 Million
70,096 Added 15.88%
511,628 $21.2 Million
Q1 2023

May 15, 2023
SELL
$56.44 - $118.81 $3.43 Million - $7.21 Million
-60,687 Reduced 12.08%
441,532 $26.6 Million
Q4 2022

Feb 14, 2023
SELL
$63.98 - $85.37 $2.26 Million - $3.02 Million
-35,375 Reduced 6.58%
502,219 $36.8 Million
Q3 2022

Nov 14, 2022
SELL
$67.99 - $89.57 $2.54 Million - $3.35 Million
-37,372 Reduced 6.5%
537,594 $40.8 Million
Q2 2022

Aug 22, 2022
BUY
$56.6 - $89.9 $2.72 Million - $4.32 Million
48,051 Added 9.12%
574,966 $40 Million
Q1 2022

May 16, 2022
SELL
$60.15 - $84.52 $2.23 Million - $3.13 Million
-37,022 Reduced 6.56%
526,915 $43.7 Million
Q4 2021

Feb 14, 2022
BUY
$75.08 - $121.99 $167,578 - $272,281
2,232 Added 0.4%
563,937 $42.3 Million
Q3 2021

Nov 15, 2021
BUY
$116.17 - $194.55 $832,241 - $1.39 Million
7,164 Added 1.29%
561,705 $65.3 Million
Q2 2021

Aug 12, 2021
BUY
$130.4 - $225.58 $4.55 Million - $7.87 Million
34,904 Added 6.72%
554,541 $123 Million
Q1 2021

May 17, 2021
BUY
$124.11 - $190.17 $27.8 Million - $42.5 Million
223,653 Added 75.56%
519,637 $68.7 Million
Q4 2020

Feb 12, 2021
BUY
$112.16 - $174.14 $22.7 Million - $35.3 Million
202,811 Added 217.67%
295,984 $51.2 Million
Q3 2020

Nov 13, 2020
BUY
$58.05 - $111.31 $164,513 - $315,452
2,834 Added 3.14%
93,173 $10.4 Million
Q2 2020

Aug 14, 2020
BUY
$57.2 - $74.41 $1.77 Million - $2.3 Million
30,964 Added 52.15%
90,339 $5.36 Million
Q1 2020

May 14, 2020
BUY
$57.05 - $95.75 $127,677 - $214,288
2,238 Added 3.92%
59,375 $4.01 Million
Q4 2019

Feb 13, 2020
BUY
$68.3 - $93.8 $458,224 - $629,304
6,709 Added 13.3%
57,137 $4.82 Million
Q3 2019

Nov 13, 2019
BUY
$61.86 - $97.8 $631,528 - $998,440
10,209 Added 25.38%
50,428 $3.77 Million
Q2 2019

Aug 14, 2019
BUY
$42.22 - $63.23 $313,061 - $468,850
7,415 Added 22.6%
40,219 $2.54 Million
Q1 2019

May 15, 2019
BUY
$31.96 - $56.12 $19,559 - $34,345
612 Added 1.9%
32,804 $1.58 Million
Q4 2018

Feb 15, 2019
BUY
$28.72 - $52.63 $119,618 - $219,203
4,165 Added 14.86%
32,192 $1.08 Million
Q3 2018

Nov 20, 2018
BUY
$32.0 - $52.4 $9,632 - $15,772
301 Added 1.09%
28,027 $1.47 Million
Q2 2018

Aug 10, 2018
BUY
$19.85 - $32.0 $142,979 - $230,496
7,203 Added 35.1%
27,726 $868,000
Q1 2018

May 17, 2018
SELL
$19.3 - $23.65 $64,114 - $78,565
-3,322 Reduced 13.93%
20,523 $447,000
Q4 2017

Feb 13, 2018
BUY
$16.3 - $21.9 $388,673 - $522,205
23,845
23,845 $482,000

Others Institutions Holding NVCR

# of Institutions
290
Shares Held
74.2M
Call Options Held
1.26M
Put Options Held
247K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.19B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email